Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Antrozous pallidus Genome sequencing and assembly, mAntPal1

PROVIDER: PRJNA878810 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
		Other
	SRR21002104_subreads.fastq.gz	Fastqsanger.gz
	SRR21002045_1.fastq.gz	Fastqsanger.gz
	SRR21002045_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 5

Similar Datasets

Antrozous pallidus

Project description:Antrozous pallidus overview

| PRJNA492358 | ENA

Antrozous pallidus isolate:US032

Project description:Antrozous pallidus isolate:US032 Genome sequencing and assembly

| PRJNA399351 | ENA

Project description:Antrozous pallidus isolate:US032 Genome sequencing and assembly

| PRJNA728710 | ENA

Antrozous pallidus isolate:TK200870

Project description:Antrozous pallidus Genome sequencing and assembly, mAntPal1, alternate haplotype

| PRJNA868181 | ENA

Antrozous pallidus isolate:TK200870

Project description:Antrozous pallidus Genome sequencing and assembly, mAntPal1, primary haplotype

| PRJNA868156 | ENA

Antrozous pallidus

Project description:Antrozous pallidus Raw sequence reads

| PRJNA492342 | ENA

Aeribacillus pallidus strain:Jh-7

Project description:Aeribacillus pallidus Genome sequencing and assembly

| PRJNA407014 | ENA

Expression analysis of dissected GPi in Parkinson's disease

Project description:Genome-wide transcriptome analysis of expression changes in Globus Pallidus interna (GPi) from Parkinson's disease brain tissue versus control brain tissue.

2010-02-04 | GSE20146 | GEO

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Trioxys pallidus

Project description:Trioxys pallidus Genome sequencing

| PRJNA260397 | ENA